US BANCORP \DE\ - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 130 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$2,890
-39.2%
1,7100.0%0.00%
Q2 2023$4,754
+113.6%
1,710
+39.8%
0.00%
Q1 2023$2,226
-61.4%
1,223
+7.7%
0.00%
Q4 2022$5,760
+188.0%
1,136
+250.6%
0.00%
Q3 2022$2,000
+100.0%
3240.0%0.00%
Q2 2022$1,000
-50.0%
3240.0%0.00%
Q1 2022$2,000
-50.0%
324
-44.7%
0.00%
Q4 2021$4,000
-84.0%
586
-77.3%
0.00%
Q3 2021$25,000
-56.1%
2,586
-35.1%
0.00%
Q2 2021$57,000
-40.0%
3,9840.0%0.00%
Q1 2021$95,0003,9840.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$3,857,0000.50%
ORACLE INVESTMENT MANAGEMENT INC 400,013$2,244,0000.44%
HARBOURVEST PARTNERS LLC 335,709$1,883,0000.38%
Winning Points Advisors, LLC 60,126$339,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$541,0000.19%
SHEETS SMITH WEALTH MANAGEMENT 203,876$1,144,0000.16%
Delphia (USA) Inc. 25,504$143,0000.11%
Clearwater Capital Advisors, LLC 147,891$830,0000.10%
Corton Capital Inc. 36,843$207,0000.09%
Virtus ETF Advisers LLC 27,343$153,0000.07%
View complete list of IMMUNITYBIO INC shareholders